Table 4.
Clinical outcomes in the high-risk group
| Cases, n (%) | Median PC at birth (range) ×109/l | ICH, n | IUFD, n | |
|---|---|---|---|---|
| Total high-risk cases | 73 | 96 (1–391) | 3 | 1a |
| Platelet count <50 × 109/l | 18 (25) | |||
| Platelet count <30 × 109/l | 16 (16) | |||
| Antenatal treatment | 56 | |||
| FBS + IVIG + steroids | 4 | 70 (17–170) | ||
| FBS + IVIG | 21 | 181 (21–391) | 1 | |
| FBS | 1 | 253 | ||
| IVIG + steroids | 3 | 60 (2–296) | ||
| IVIG | 27 | 63 (10–340) | 2 | 1a |
1 case suffering from ICH ended in IUFD.